AnatomiaMalattieSostanze chimiche e FarmaciTecniche ed apparecchiature analitiche, diagnostiche e terapeuticheScienze biologicheScienze naturaliTecnologia, Industria, AgricolturaScienza dell'informazioneGruppi di personeAssistenza sanitariaLuoghi geografici
Venous ThromboembolismTromboemboliaTrombosi VenosaEmbolia PolmonareAnticoagulantiEparina A Basso Peso MolecolareTrombofiliaTromboflebiteProdotti Di Degradazione Del Fibrinogeno E Della FibrinaEnoxaparinaEmorragiaStockings, CompressionWarfarinaFattore VFattori Di RischioDispositivi A Compressione Pneumatica IntermittenteFiltri Della Vena CavaContraccettivi Orali CombinatiRicadutaProtrombinaVitamina KEparinaResistenza Alla Proteina C AttivataIncidenzaDalteparinaInternational Normalized RatioFibrinoliticiDesogestrelComplicanze PostoperatoriePostthrombotic SyndromeAndrosteniComplicanze Ematologiche Della GravidanzaValutazione Del RischioDeficit Di Proteina CCarenza Di Proteina SFlebografiaBendeLevonorgestrelTiofeniStudi ProspetticiTrombosiBeta-AlaninaAustriaFattore XaNorpregneniNeoplasieStudi RetrospettiviContraccettivi Orali SinteticiPractice Guidelines as TopicAcenocumaroloRischioComplicanze Cardiovascolari Della GravidanzaEsito Della TerapiaContraccettivi OraliStudi Di CoorteCompression BandagesCoagulazione Del SanguePiridoniArtroplastica Sostituttiva Del GinocchioSomministrazione OraleIniezioni SottocutaneeStudi Follow-UpImmobilizzazioneFattori TemporaliOspedalizzazioneStudi Caso-ControlloProteina CAntitrombineArtroplastica Sostitutiva Dell'AncaMedicina AerospazialeGravity SuitsNumero Di Posti Letto Da 300 A 499Metodo A Doppio CiecoFattori Di Coagulazione Del SangueProcedure OrtopedicheFattore ViiiOsservanza Di Linee GuidaDeficit Di Antitrombina IiiTempo Di Tromboplastina ParzialeRandomized Controlled Trials as TopicPolisaccaridiSchema Di Somministrazione FarmacologicaPremedicazioneMorfolinePazienti InterniCarenza Del Fattore VDisturbi Del PuerperioProve Di Coagulazione Del SangueSindrome AntifosfolipidicaAnticorpi AntifosfolipidiciFattori Dell'EtàBenzimidazoliAspirinaContraccetivi Orali OrmonaliTerapia Sostitutiva Degli EstrogeniVena FemoraleAmbulazione PrecoceDispositivi Intrauterini A Rilascio Di Agenti ChimiciBenzilamineSindrome Postflebitica
PatientsPreventionRiskMedical OncologySafetyGuidelines
Patients6
  • Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. (unifi.it)
  • Is There a Role for Anti-factor Xa Activity Assay in Venous Thromboembolism Prophylaxis Management Among Orthopaedic Trauma Patients? (anticoagulazione.it)
  • Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. (ematoinfo.it)
  • Venous thromboembolism (VTE) - includes deep vein thrombosis (DVT) and pulmonary embolism (PE) - affects 1 out every 1000 in-patients in the US and is the second leading cause of medical complications resulting in lengthening hospital stays. (wellell.com)
  • Thanks to more and more effective antineoplastic treatments the survival of cancer patients is enormously increasing, but at the same time it is increasing the burden of related cardiovascular complications that affect morbidity and mortality. (cardioncology.org)
  • The proposed sections of the book have been structured to review the molecular mechanisms underlying vascular damage induced by new and old treatments, to describe the various manifestations of vascular disease that may range from artery to venous disease (including coronary artery disease, peripheral arterial disease, venous thromboembolism and pulmonary hypertension), and to provide advice to monitor patients undergoing onco-hematologic treatments in order to prevent and eventually manage vascular damage. (cardioncology.org)
Prevention1
  • PINO 2009 LMWH The purpose of this review is to provide updated evidence on the use of low-molecular-weight heparins for prevention of venous thromboembolism after the publication of the latest Anerican College of Chest Physicians Evendeced-Based Clinical Practice on antithrombotic and thrombolytic therapy. (andreozzi.eu)
Risk5
  • New agents in medical oncology and the risk of venous thromboembolism. (unipv.it)
  • Hastie GR, Pederson A, Redfern D. Venous thromboembolism incidence in upper limb orthopedic surgery: do these procedures increase venous thromboembolism risk? (giot.it)
  • Keller K, Hobohm L, Engelhardt M. Risk of venous thromboembolism after endoprosthetic surgeries: lower versus upper extremity endoprosthetic surgeries. (giot.it)
  • Increased anaesthesia duration increases venous thromboembolism risk in plastic surgery: A 6-year analysis of over 19,000 cases using the NSQIP dataset. (giot.it)
  • The possible association between conventional antipsychotic drugs and deep venous thrombosis, followed by pulmonary embolism, in a man with no predisposing risk factors, as well as the question concerning the appropriateness of medical care, are discussed. (uniroma1.it)
Medical Oncology1
  • Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM). (fondazioneartet.it)
Safety1
  • National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism. (flo.health)
Guidelines1
  • Ricci JA, Crawford K, Ho OA, Lee BT, Patel KM, Iorio ML. Practical Guidelines for Venous Thromboembolism Prophylaxis in Free Tissue Transfer. (giot.it)